BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quan J, Li Y, Jin M, Chen D, Yin X, Jin M. Suppression of p53-inducible gene 3 is significant for glioblastoma progression and predicts poor patient prognosis. Tumour Biol 2017;39:1010428317694572. [PMID: 28351326 DOI: 10.1177/1010428317694572] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Ni Y, He J, Chalise P. Integration of differential expression and network structure for 'omics data analysis. Comput Biol Med 2022;150:106133. [PMID: 36179515 DOI: 10.1016/j.compbiomed.2022.106133] [Reference Citation Analysis]
2 Niu N, Li Y, Yu H, Guo L, Guo Z, Lan S, Liu Q, Zhang Y, Gui J, Wu D. The oncogenic function and potential mechanism of basic transcription factor 3 in melanoma.. [DOI: 10.21203/rs.3.rs-1946197/v1] [Reference Citation Analysis]
3 Haehnel S, Rade M, Kaiser N, Reiche K, Horn A, Loeffler D, Blumert C, Rapp F, Horn F, Meixensberger J, Renner C, Mueller W, Gaunitz F, Bechmann I, Winter K. RNA sequencing of glioblastoma tissue slice cultures reveals the effects of treatment at the transcriptional level. FEBS Open Bio 2021. [PMID: 34923780 DOI: 10.1002/2211-5463.13353] [Reference Citation Analysis]
4 Lai KP, Cheung A, Ho CH, Tam NY, Li JW, Lin X, Chan TF, Lee NP, Li R. Transcriptomic analysis reveals the oncogenic role of S6K1 in hepatocellular carcinoma. J Cancer 2020;11:2645-55. [PMID: 32201535 DOI: 10.7150/jca.40726] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Osei E, Walters P, Masella O, Tennant Q, Fishwick A, Dadzie E, Bhangu A, Darko J. A review of predictive, prognostic and diagnostic biomarkers for brain tumours: towards personalised and targeted cancer therapy. J Radiother Pract 2021;20:83-98. [DOI: 10.1017/s1460396919000955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
6 Talib WH, Al-Hadid SA, Ali MBW, Al-Yasari IH, Ali MRA. Role of curcumin in regulating p53 in breast cancer: an overview of the mechanism of action. Breast Cancer (Dove Med Press) 2018;10:207-17. [PMID: 30568488 DOI: 10.2147/BCTT.S167812] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
7 Gu MM, Gao D, Yao PA, Yu L, Yang XD, Xing CG, Zhou J, Shang ZF, Li M. p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma. Cancer Sci 2018;109:3783-93. [PMID: 30281878 DOI: 10.1111/cas.13818] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
8 Urhie O, Turner R, Lucke-Wold B, Radwan W, Ahn J, Gyure K, Bhatia S. Glioblastoma Survival Outcomes at a Tertiary Hospital in Appalachia: Factors Impacting the Survival of Patients Following Implementation of the Stupp Protocol. World Neurosurg 2018;115:e59-66. [PMID: 29631083 DOI: 10.1016/j.wneu.2018.03.163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
9 Qixing M, Gaochao D, Wenjie X, Anpeng W, Bing C, Weidong M, Lin X, Feng J. Microarray analyses reveal genes related to progression and prognosis of esophageal squamous cell carcinoma. Oncotarget 2017;8:78838-50. [PMID: 29108269 DOI: 10.18632/oncotarget.20232] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]